Ultragenyx Pharmaceutical Inc (RARE)

69.80
1.80 2.50
NASDAQ : Health Care
Prev Close 71.56
Open 71.26
Day Low/High 70.20 / 71.83
52 Wk Low/High 46.52 / 135.43
Volume 270.87K
Avg Volume 613.00K
Exchange NASDAQ
Shares Outstanding 39.44M
Market Cap 2.87B
EPS -4.00
P/E Ratio 27.87
Div & Yield N.A. (N.A)

Latest News

Ultragenyx Reports Positive Interim Data From Phase 2 Study Of KRN23 For The Treatment Of Tumor-Induced Osteomalacia

Ultragenyx Reports Positive Interim Data From Phase 2 Study Of KRN23 For The Treatment Of Tumor-Induced Osteomalacia

Company to host conference call at 11am ET Monday, September 19 to discuss results

These 5 Stocks Are Breaking Out This Summer

These 5 Stocks Are Breaking Out This Summer

These five technical setups are showing solid upside potential right now.

16 Biopharma Companies Besides Medivation That Are Attractive Targets

16 Biopharma Companies Besides Medivation That Are Attractive Targets

Besides Sanofi, Biogen is the next most likely to complete a sizable transaction in the next 12 months, according to Credit Suisse analysts.

Ultragenyx Announces Data Presentations Of RhGUS And RhPPCA At 12th Annual WORLD Symposiumâ„¢

Ultragenyx Announces Data Presentations Of RhGUS And RhPPCA At 12th Annual WORLD Symposiumâ„¢

Ultragenyx CEO Emil Kakkis, M.D. Ph.D., Receives 2016 Lysosomal Disease Network Award for Innovation and Achievement

Ultragenyx Pharmaceutical (RARE) Stock Gets 'Outperform' Rating at Leerink

Ultragenyx Pharmaceutical (RARE) Stock Gets 'Outperform' Rating at Leerink

Leerink began coverage of Ultragenyx Pharmaceutical (RARE) stock with an 'outperform' rating and $80 price target on Friday morning.